Table 2.
Author | Age | Gender (Female) | Antidepressant | Pretreatment | Posttreatment | ||||
---|---|---|---|---|---|---|---|---|---|
N | Serum BDNF | SD | N | Serum BDNF | SD | ||||
Huang(47) | 37.3 | 0.77 | SSRIs and Venlafaxine | 79 | 10.7 | 8.9 | 79 | 12 | 8.9 |
Piccinni(19) | 47.0 | 0.87 | SSRIs and TCAs | 15 | 19.3 | 8.8 | 7 | 18.8 | 4.1 |
Yoshimura(18) | 46.5 | 0.62 | Paroxetine and Milnacipran | 42 | 9.5 | 7.8 | 42 | 17.7 | 8.1 |
Aydemir – A(45) | 35.6 | 1 | Escitalopram | 20 | 27.7 | 13.7 | 20 | 38.6 | 15.3 |
Gervasoni(44) | 40.5 | 0.58 | Paroxetine, Venlafaxine, Clomipramine and Lithium | 26 | 22.6 | 3.6 | 26 | 24.4 | 3.6 |
Gonul(48) | 35.5 | 0.75 | SSRIs and Venlafaxine | 28 | 20.8 | 6.7 | 28 | 33.3 | 9.9 |
Aydemir – B(46) | 31.8 | 0.80 | Venlafaxine | 10 | 17.9 | 9.1 | 10 | 34.6 | 7.1 |
Hellweg(50) | 50.5 | 0.78 | Amitriptyline and Paroxetine | 40 | 13.1 | 4.4 | 40 | 13.6 | 5.4 |